Three exons in the fibronectin primary transcript are alternatively spliced in a tissue-and developmental stage-specific manner. One of these exons, EDA, has been shown previously by others to contain two splicing regulatory elements between 155 and 180 nucleotides downstream of the 3-splice site: an exon splicing enhancer and a negative element. By transient expression of a chimeric ␤-globin/fibronectin EDA intron in COS-7 cells, we have identified two additional exonic splicing regulatory elements. RNA generated by a construct containing the first 120 nucleotides of the fibronectin EDA exon was spliced with an efficiency of approximately 50%. Deletion of most of the fibronectin EDA exon sequences resulted in a 20-fold increase in the amount of spliced RNA, indicative of an exon splicing silencer. Deletion and mutagenesis studies suggest that the fibronectin exon splicing silencer is associated with a conserved RNA secondary structure. In addition, sequences between nucleotides 93 and 118 of the EDA exon contain a non-purine-rich splicing enhancer as demonstrated by its ability to function in a heterologous context.
Three exons in the fibronectin primary transcript are alternatively spliced in a tissue-and developmental stage-specific manner. One of these exons, EDA, has been shown previously by others to contain two splicing regulatory elements between 155 and 180 nucleotides downstream of the 3-splice site: an exon splicing enhancer and a negative element. By transient expression of a chimeric ␤-globin/fibronectin EDA intron in COS-7 cells, we have identified two additional exonic splicing regulatory elements. RNA generated by a construct containing the first 120 nucleotides of the fibronectin EDA exon was spliced with an efficiency of approximately 50%. Deletion of most of the fibronectin EDA exon sequences resulted in a 20-fold increase in the amount of spliced RNA, indicative of an exon splicing silencer. Deletion and mutagenesis studies suggest that the fibronectin exon splicing silencer is associated with a conserved RNA secondary structure. In addition, sequences between nucleotides 93 and 118 of the EDA exon contain a non-purine-rich splicing enhancer as demonstrated by its ability to function in a heterologous context.
Higher eukaryotes have evolved alternative splicing as a common means of producing several different mRNAs and polypeptides from a single primary transcript (for review, see Ref. 1) . Transcripts that undergo alternative splicing can produce mRNAs and proteins with different structures, properties, and functions. The utilization of alternative splice sites can be regulated to prevent the inappropriate accumulation of one or more alternative products. To date, several examples of cisacting regulatory elements, distinct from bona fide splice sites, have been identified which modulate splicing in a diverse assortment of genes from viruses (2-10), Drosophila (11) (12) (13) (14) , and higher eukaryotes (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) .
The fibronectin gene is a classical example of a gene that undergoes alternative splicing (34, 35) . The fibronectin gene is evolutionarily conserved and is predicted to yield up to 20 different mRNAs in human cells. The generation of this remarkable number of different mRNAs, and consequently polypeptides, is made possible by alternative splicing in three different coding regions of the fibronectin primary transcript (for review, see Refs. 36 and 37). One of the alternatively spliced regions encompasses the EDA (also referred to as EIIIA or EDI) exon. This exon is excluded selectively in fibronectin mRNAs produced by hepatocytes, but it is included to various extents by other cell types (Fig. 1A) . EDA exon splicing is also subject to developmental regulation as EDA exon inclusion generally declines with age and differentiation (36, 37) . In addition to tissue-specific and developmental regulation, inclusion of the EDA exon is modulated during the process of tissue repair and in certain diseases.
For these reasons, regulation of fibronectin EDA exon splicing has been the subject of several studies. In fact, the EDA exon was the first exon with which it was demonstrated that proper alternative splicing could occur in the context of transfected minigenes (38) . Using the same experimental approach, it was determined subsequently that the central 81 nucleotides of the 270-nucleotide EDA exon were required for its inclusion into mRNA (31) . Using a chimeric adenovirus/fibronectin EDA intron substrate in an in vitro splicing system, Lavigueur et al. (32) further mapped the element required for EDA exon inclusion to a 9-nucleotide purine-rich motif (5Ј-GAAGAAGAC-3Ј). Caputi et al. (33) identified the same purine-rich sequence as a positive cis-acting element by transfection experiments. Similar exonic purine-rich motifs have been demonstrated to stimulate splicing (39 -41) and have been termed exon recognition sequences or exon splicing enhancers (ESEs). 1 A negative element (5Ј-CAAGG-3Ј) involved in down-regulation of EDA exon inclusion was also identified within the EDA exon just downstream of the ESE (33) . Although the ESE within the EDA exon has been demonstrated (32) to interact with splicing factors belonging to a family of serine/arginine-rich RNA-binding proteins collectively termed SR proteins (42), it is not yet known if trans-acting factors interact with the negative element.
Using a chimeric intron composed of sequences flanking the 5Ј-splice site (5Јss) of the first intron of human ␤-globin and sequences flanking the 3Ј-splice site (3Јss) of the human fibronectin EDA exon (2), we observed that deletion of most of the fibronectin EDA exon sequences resulted in a dramatic increase in splicing efficiency. We have carried out mapping experiments to characterize this novel exon splicing silencer (ESS) element. Closer examination of the ESS revealed an adjacent positive element that is able to stimulate splicing when placed downstream of a heterologous intron. This novel ESS and adjacent positive element represent the third and fourth splicing regulatory elements to be identified within the 270-nucleotide EDA exon. The presence of so many different regulatory elements is of particular interest because they may explain the complex, dynamic splicing pattern exhibited by the fibronectin EDA exon.
EXPERIMENTAL PROCEDURES
Plasmid Constructions-All plasmids are derivatives of pSV␤FN- (2) . Truncation of fibronectin exon sequences (accession no. X07718) was carried out by PCR using the sense primer FN3Јss, 5Ј-CGT CGA CAA AGA AAA TGG TAT CTG C-3Ј (nucleotides 1146 -1164) and the following antisense primers: ⌬, 5Ј-CCC CCG GAT CCA ATG CCA GTC CTT TAG GG-3Ј (nucleotides 1255-1272); ⌬1, 5Ј-CGG GAT CCC ACC CTG TAC CTG GA-3Ј (nucleotides 1331-1345); ⌬2, 5Ј-CGG GAT CCA ACT TGC CCC TGT GG-3Ј (nucleotides 1316 -1330); ⌬3, 5Ј-CGG GAT CCG CTT TCC CAA GCA AT-3Ј (nucleotides 1301-1315); and ⌬4, 5Ј-CGG GAT CCT TTG ATG GAA TCG AC-3Ј (nucleotides 1286 -1300) to generate the respective constructs. The mod series of fibronectin exon mutations was carried out by PCR-mediated site-directed mutagenesis as described previously (43) using the FN3Јss sense primer and the antisense primer CATR1 (described below) along with the following mutagenic primers: mod1, 5Ј-CAC AGG GGC AAG atc TAC AGG GTG ACC-3Ј (nucleotides 1317-1348); mod2, 5Ј-CAT CAA AAT TGC aga tct CAC AGG GGC AAG-3Ј (nucleotides 1294 -1328); and mod3, 5Ј-CAC TGA TGT GGA gat cTC AAA ATT GCT T-3Ј (nucleotides 1273-1307) to generate the respective constructs. Lowercase letters indicate nucleotides introduced to create a unique BglII restriction enzyme site (underlined). The single stem-loop 1 mutation (SL1B) was generated in a similar fashion using the mutagenic primer SL1B, 5Ј-TCA CTG ATG TGG tac TCG ATT CCA T-3Ј (nucleotides 1272-1296), except that it was introduced in the context of the ⌬1 truncation. The single stem-loop 2 mutation (SL2B) was generated in the context of the ⌬1 truncation by PCR using FN3Јss sense primer and the SL2B antisense primer 5-CCG GAT CCC ACC CTG TAC Cac cAA ACT TGC CCC TGT G-3Ј (nucleotides 1317-1345). The double stem-loop 2 mutation (SL2TB) was derived from pSV␤FNSL2B by PCR-mediated site-directed mutagenesis using the mutagenic primer SL2T, 5Ј-GAT TCC ATC AAA ATT GCT acc GAA AGC CCA CAG-3Ј (nucleotides 1289 -1321). The double stem-loop 1 mutation (SL1TB) was generated as follows. The PCR product generated using the FN3Јss/SL1T primer pair was gel purified and mixed with an equimolar amount of gel purified PCR product generated with the SL1T, 5Ј-CCA CAT CAG TGA tac CCA GTC CTT T-3Ј (nucleotides 1259 -1283)/CATR1 (described below) primer pair. One end of each of these two DNA fragments contains a 12-bp overlap flanked by either the SL1B or SL1T mutation. By virtue of this 12-bp overlap, the two fragments were annealed and elongated by 10 cycles of low stringency PCR (25°C annealing step) and then amplified by 25 cycles of normal stringency PCR (55°C annealing step) using the FN3Јss/CATR1 primer pair. Approximately 75% of clones sequenced contained the desired double mutation. The SalI-BamHI fragments of truncated or mutated PCR products were reinserted into the SalI and BamHI sites of pSV␤FN-.
The plasmid pSVCBSB has been described previously (43) . Its derivatives, containing fibronectin EDA exon sequences in the sense (pSVCBSBFs) or antisense (pSVCBSBFas) orientation, were generated by inserting the 30-bp BglII-BamHI fragment of pSV␤FNmod1 into the unique BamHI site of pSVCBSB. The ϩ1C, ⌬5Јss, and ⌬AC mutations were introduced in the context of pSVCBSBFs by PCR using the sense primer ␤PCR1, 5Ј-CTT AAG TTG GTG GTG AGG-3Ј (43) , in conjunction with the following antisense primers: ϩ1C, 5Ј-CGG ATC CGG TCA GGG CTA GAG TAG GTC AgC CTG TAG ATC CG-3Ј (nucleotides 1337-1362); ⌬5Јss, 5Ј-CCG GAT CCG GTC AGG GCT CGA GTA GGT TGT AGA TCC GGT CTG-3Ј (nucleotides 1337-1340, 1346 -1362); and ⌬AC, 5Ј-CCG GAT CCG GTC ACC CTG TAG ATC CG-3Ј (nucleotides 1337-1348). The SalI-BamHI fragments of the resulting PCR products were reinserted into the SalI and BamHI sites of pSVCBSB.
Cell Transfection and RNA Analysis-COS-7 cells (ATCC CRL1651) were transfected as described previously (44) with 5 g of plasmid DNA/100-mm Petri dish. 48 h post-transfection, cells were washed once with ice-cold phosphate-buffered saline, lysed directly on the culture dish by the addition of 1 ml of 4 M guanidine thiocyanate, 25 mM sodium citrate (pH 7.0), 0.5% sarkosyl, and 0.1 M ␤-mercaptoethanol, and total RNA was isolated as described previously (45) . When actinomycin D was used, the drug was added to the culture medium 48 h post-transfection at a final concentration of 5 g/ml, and total RNA was extracted as described above at the indicated times.
To generate probes for S1 nuclease analysis, the XhoI-SalI fragment of each construct was deleted, and the resulting plasmids were linearized with PvuI. Linearized plasmids were used as templates for primer extension using the 5Ј-end labeled antisense primer CATR1, 5Ј-CGG AAT TCC GGA TGA GCA TT-3Ј, which overlaps the EcoRI restriction endonuclease site of the chloramphenicol acetyltransferase (CAT) open reading frame. 50 fmol of PvuI-linearized template DNA and 1 pmol of 5Ј-end-labeled CATR1 primer were subjected to 15 thermal cycles (1 min at 94°C, 30 s at 55°C, and 1.5 min at 72°C) with 2 units of Taq DNA polymerase in a 20-l reaction. Free CATR1 primer was removed by agarose gel purification of the extended primer. S1 nuclease protection assays were carried out as described previously (43) using 10 g of total RNA and 5-10 ϫ 10 4 cpm (approximately 50 -100 fmol) of the appropriate probe. S1-resistant probe DNA fragments were subjected to electrophoresis on 4% polyacrylamide, 8 M urea gels and subsequently visualized and quantitated using a PhosphorImager (Molecular Dynamics). All cited ratios of spliced to unspliced RNAs are averages of results obtained in at least three independent experiments.
RESULTS
Fibronectin EDA Exon Sequences Are Implicated in Repression of Splicing-In previous studies, our laboratory generated a chimeric gene composed of sequences flanking the 5Јss of the first intron of the human ␤-globin gene and sequences flanking the 3Јss upstream of the EDA exon of the human fibronectin gene (2) . The fibronectin sequences within the chimeric construct include 99 nucleotides of the intron and the first 118 nucleotides of the EDA exon (Fig. 1B) . The previously characterized purine-rich ESE and the adjacent negative element, which are located between 155 and 180 nucleotides downstream of the EDA 3Јss, are not present in pSV␤FN-and thus do not contribute to the level of splicing observed. S1 analysis of RNA isolated from transfected COS-7 cells showed that splicing of pSV␤FN-RNA is relatively inefficient and results in the accumulation of roughly equal amounts of spliced and unspliced RNA (Fig. 1C, lane 1) . In an attempt to study the positional effect of a heterologous ESS element, we generated a truncated form of the EDA exon (designated pSV␤FN⌬; see Fig. 2) in which sequences from ϩ28 to ϩ118 were deleted. Deletion of these sequences resulted in a 20-fold increase in the ratio of spliced to unspliced (S:U) RNA (Fig. 1C, lane 2) . This finding indicates that a splicing silencer element may exist within this region of the fibronectin EDA exon and that the EDA 3Јss may be intrinsically efficient.
Mapping the Fibronectin EDA ESS-To map the fibronectin ESS element, we generated sequential 3Ј-truncations of the EDA exon sequences (Fig. 2 ). S1 analysis of RNA from COS-7 cells transfected with pSV␤FN⌬1, ⌬2, ⌬3, or ⌬4 (Fig. 3) revealed that, with the exception of ⌬1 (lane 2), splicing efficiency steadily increased as fibronectin EDA exon sequences were progressively shortened (lanes [3] [4] [5] ; the ratio of spliced to unspliced RNA approached that obtained with pSV␤FN⌬. The ⌬1 truncation defines the 3Ј-boundary of the fibronectin ESS as nucleotide ϩ101 relative to the EDA 3Јss. The correlation between the size of the truncation and the splicing efficiency observed with ⌬2, ⌬3, and ⌬4 suggests that the fibronectin ESS may be comprised of multiple smaller elements dispersed within the first 100 nucleotides of the EDA exon or that its function is dependent upon the stability of a secondary structure.
However, based on the effect of these 3Ј-deletions alone, we could not exclude the possibility that the progressive increase in splicing is caused by the positioning of CAT sequences closer to the EDA 3Јss and not by disruption of an ESS within the EDA exon. To test this possibility, we used site-directed mutagenesis to introduce small internal deletions in the EDA exon within the context of pSV␤FN- (Fig. 2) . The net effect of these internal modifications is a 5-nucleotide deletion in pSV␤FNmod1 and pSV␤FNmod2 and a 7-nucleotide deletion in pSV␤FNmod3. All three mutations resulted in a moderate (4 -8-fold) increase in splicing efficiency (Fig. 4) . These results suggest that the effects seen in Fig. 3 are caused by deletion of a splicing silencer element between nucleotides ϩ28 and ϩ101 rather than by movement of CAT sequences closer to the EDA 3Јss. To verify that the alteration in the spliced:unspliced RNA ratio is not attributable to differences in RNA stability, the half-life of the spliced and unspliced RNAs of several constructs was examined. As indicated in Fig. 5 , all three constructs tested had half-lives of approximately 6 h for spliced RNA (filled circles) and 2-4 h for unspliced RNA (empty circles).
Thus, no apparent difference in the stability of spliced RNA was observed among pSV␤FN-, pSV␤FNmod3, and pSV␤FN⌬4. Therefore, the marked increase in accumulation of spliced RNA cannot be attributed to a longer half-life. The small decrease in half-life observed for the unspliced RNA of pSV␤FN⌬4 compared with that of pSV␤FN-or pSV␤FNmod3 is consistent with more efficient splicing kinetics.
Identification of a Non-purine-rich Splicing Enhancer within the EDA Exon-The complete abrogation of splicing observed with the pSV␤FN⌬1 construct suggests that the sequences deleted in pSV␤FN⌬1 (nucleotides 102-118) harbor a splicing enhancer element. However, if that is the case, it differs from "classical" ESE elements (39 -41) in that it is not purine-rich. To test if these EDA exon sequences could stimulate splicing when placed in a heterologous context, nucleotides 93-118 of the EDA exon were inserted into pSVCBSB (Fig. 6A) downstream of a chimeric ␤-globin/HIV-1 intron. The pSVCBSB chimeric intron is not spliced (43) since critical HIV-1 exon splicing regulatory elements have been deleted (2) . We have demonstrated previously that splicing of this intron can be stimulated significantly by several classical purine-rich ESEs, including the ESE within the fibronectin EDA exon. Consistent with our previously published results (43) , only trace amounts of spliced RNA were detected with pSVCBSB (Fig. 6B, lane 1) . Insertion of nucleotides 93-118 of the EDA exon in the sense orientation (pSVCBSBFs) stimulated splicing at least 25-fold (Fig. 6B, lane 2) . Conversely, insertion of the same EDA sequences in the antisense orientation did not have a stimulatory effect on splicing (Fig. 6B, lane 3) .
The region associated with enhancer activity contains the sequence 5Ј-AGGGTGACC-3Ј, which bears homology (a 6 out of 9 match; underlined) to the 5Јss consensus sequence, 5Ј-(C/ A)AGGT(A/G)AGT-3Ј. One model to explain how this novel enhancer functions is that this pseudo-5Јss element recruits U1 snRNP to stimulate recognition of the EDA 3Јss much like authentic 5Ј-splice sites have been demonstrated to stimulate exon recognition (46, 47) . To examine this possibility, we introduced a point mutation that converted the critical GT dinucleotide of the pseudo-5Јss to CT (designated ϩ1C in Fig. 6C ), deleted the majority of the pseudo-5Јss (Fig. 6C, ⌬5Јss) , or deleted the A/C-rich region immediately downstream of the pseudo-5Јss (Fig. 6C, ⌬AC) . Analysis of the effect of these mutations revealed that none of the mutations tested resulted in loss of enhancer function. Rather, in all cases the mutation resulted in a further enhancement in the ratio of spliced to unspliced RNA (Fig. 6D, compare lanes 3-5 with lane 2) . Therefore, the splicing enhancer activity associated with this nonpurine-rich sequence cannot be attributed solely to the 5Јss-like element.
The Fibronectin ESS Can Potentially Form a Stable, Conserved Secondary Structure-The relatively large size of the fibronectin ESS prompted us to examine its ability to form a secondary structure. The 118 nucleotides of the EDA exon present in pSV␤FN-are predicted to form three stem-loops (Fig. 7A) . Each of the two stem-loops closest to the EDA 3Јss contains a hairpin loop of 4 nucleotides and an internal loop that interrupts the 13-bp stem. The third and most distal stem-loop is predicted to consist of a stem of only 6 bp and a relatively large loop of 11 nucleotides. The fibronectin gene and its alternative splicing patterns are highly conserved among human, rat, and chicken (36, 37) . Therefore, we examined whether the first 118 nucleotides of the EDA exon of other species retained the potential to form a secondary structure similar to that in Fig. 7A . Fibronectin sequences of different species were obtained from sequence data bases and aligned (Fig. 7B) . Compared with the human fibronectin sequence, the The bracket indicates the sequences studied in this report. The schematic is not drawn to scale. Panel B, parent plasmid used to study exon splicing regulatory elements. Fibronectin sequences are shown in gray and include the first 118 nucleotides of the EDA exon and 99 nucleotides of the upstream intron. The promoter (arrow) and polyadenylation signal (pA) are from SV40. CAT denotes the coding region of chloramphenicol acetyltransferase. ␤ 5Јss denotes the 5Јss of the first intron of the human ␤-globin gene; FN 3Јss denotes the fibronectin EDA 3Јss. The previously characterized ESE (5Ј-GAAGAAGAC-3Ј) and negative (5Ј-CAAGG-3Ј) elements are located at positions ϩ156 and ϩ176 relative to the EDA 3Јss, respectively, and are thus not present in pSV␤FN or any of its derivatives described in this paper. 5Ј-End-labeled probes used for S1 analysis, depicted below the figure, span part of the CAT gene and the entire fibronectin segment (which varies among the different derivatives of pSV␤FN-) and contain heterologous sequences (wavy line) at their 3Ј-ends. The XhoI, SalI, and BamHI restriction endonuclease sites described under "Experimental Procedures" are situated just upstream of the promoter, at the 5Ј-end of the fibronectin sequences and at the 3Ј-end of the fibronectin sequences, respectively. The schematic is not drawn to scale. Panel C, deletion of fibronectin exon sequences results in increased splicing. S1 nuclease protection analysis was carried out with 10 g of total RNA from COS-7 cells transfected with either pSV␤FN-(described in panel B) or pSV␤FN⌬, a derivative containing only 28 nucleotides of the EDA exon (see Fig. 2 ). Each sample was hybridized with the homologous probe as depicted in EDA exons from fibronectin of other mammals such as dog, rat, and mouse differ by only a few nucleotides, whereas those of chicken, newt, and frog are slightly more divergent. As expected, most of these nucleotide substitutions are silent at the amino acid level. The interesting observation is the occurrence of covariance and conservative substitutions.
The region comprising step-loop 1 is completely conserved among human, dog, and rat fibronectin sequences. Chicken, newt, and frog fibronectin sequences contain several substitutions that do not compromise the ability of this region to form step-loop 1. An example of covariance is seen in chicken fibronectin involving positions ϩ23 and ϩ44. As depicted in Fig.  7A , the nucleotides at these two positions are predicted to form a G-C bp in stem-loop 1. In chicken fibronectin, the nucleotide at ϩ23 is replaced by an A, and a compensatory C 3 T substitution occurs at nucleotide ϩ44, thus maintaining the ability to form a canonical Watson-Crick bp. Several examples of conservative substitutions involving putative base pairing between G and U residues are also observed. In both chicken and frog, a G-U bp in stem-loop 1 is converted to a canonical A-U bp by a G 3 A substitution at position ϩ24. Examples in which canonical Watson-Crick bp are replaced by a wobble bp are also observed. In frog, a U-A bp is converted to a U-G bp by an A 3 G substitution at ϩ40, and a G-C bp is converted to a G-U bp by a C 3 T substitution at ϩ44. Taken together, these examples of covariance and conservative nucleotide substitutions support the notion that the stem-loop 1 secondary structure depicted in Fig. 7A is absolutely conserved and is indicative of selective   FIG. 2 . Summary of constructs used to study the EDA ESS. Sequences are shown in the 5Ј 3 3Ј orientation, starting with the first nucleotide of the EDA exon. The T at position ϩ110 differs from the published sequence (48) in which it was reported to be a G. Truncations (⌬, ⌬1, ⌬2, ⌬3, and ⌬4) used to map the 3Ј-boundary of the ESS are indicated by arrowheads above the sequence. Small internal deletions and unique BglII restriction sites created by site-directed mutagenesis (mod1, mod2, and mod3) are shown below the sequence. Asterisks indicate deleted nucleotides, and lowercase letters indicate substitutions introduced to create the restriction endonuclease site. The first few nucleotides of vector sequences immediately downstream of the truncation points are shown in italics. The BamHI site described under "Experimental Procedures" is underlined. The pSV␤FN-construct contains the dinucleotide CC (which originated from a BamHI linker; see Ref.
2) between the fibronectin sequences and the vector sequences. Inclusion of downstream vector sequences in the secondary structure analysis did not alter the predicted stem-loops 1 and 2 depicted in panel A of Fig. 7.   FIG. 3 . Mapping the ESS using 3-deletions of the EDA exon. The truncations are described in Fig. 2 . S1 nuclease protection analysis was carried out using 10 g of total RNA from transfected COS-7 cells. Each sample was hybridized with the homologous probe as depicted in Fig. 1B . Positions of the protected probe fragments are indicated: U, unspliced RNA; S, spliced RNA. Ratios of spliced to unspliced RNA are shown at the bottom of each lane. Fig. 2 . S1 nuclease protection analysis was carried out using 10 g of total RNA from transfected COS-7 cells. Each sample was hybridized with the homologous probe as depicted in Fig. 1B . Positions of the protected probe fragments are indicated: U, unspliced RNA; S, spliced RNA. Ratios of spliced to unspliced RNA are shown at the bottom of each lane. pressure for maintenance of this secondary structure in addition to the protein-coding potential.
FIG. 4. Effect of internal deletions on ESS function. Deletions are described in
Compared with stem-loop 1, there are only a few examples of covariance or conservative substitutions in the region comprising the putative stem-loop 2. For example, a U-G bp in stemloop 2 is converted to a canonical C-G bp by a T 3 C substitution at ϩ62 in rat fibronectin. In newt fibronectin, the C at ϩ61 is replaced by a T, and a compensatory G 3 A substitution occurs at nucleotide ϩ92, thus maintaining the ability to form a canonical Watson-Crick bp. However, the secondary structure of stem-loop 2 is not as evolutionarily conserved as that of stem-loop 1. For example, the bulge in stem-loop 2 is enlarged by substitutions at positions ϩ86 and ϩ87 in chicken fibronectin. These same two substitutions combined with others just downstream abolish the ability to form the base of stem-loop 2 in both newt and frog.
To test the validity of the predicted secondary structure, we introduced mutations in the predicted stem-loop 1 or 2 which would disrupt the secondary structure, and we then made second site mutations that were predicted to restore the secondary structure but alter the primary sequence (Fig. 7B) . We targeted the most extensive base paired regions of the stemloops: in the middle of stem-loop 1 and at the base of stem-loop 2 (boxed in Fig. 7A ). To maximize the sensitivity of the assay, all mutations were introduced in the context of the ⌬1 truncation so that the effect of the adjacent ESE would not confound interpretation of the results. Disruption of stem-loop 1 (SL1B) resulted in partial loss of ESS function (Fig. 7C, lane 2) which was restored (lane 3) upon introducing the second site mutation (SL1TB), which regenerated the secondary structure. In contrast, disruption of the base pairing at the base of stem-loop 2 (SL2B) was found to have no effect on ESS function (lane 4). A second site mutant (SL2TB), predicted to restore the base pairing of the lower stem of stem-loop 2, was found to have a very slight reduction of ESS function. Based on the SL2 mutations, it appears that formation of the lower stem of stem-loop 2 is not essential for ESS activity.
DISCUSSION
Transient transfection of COS-7 cells with a plasmid containing a chimeric gene containing the first 118 nucleotides of the fibronectin EDA exon and upstream intron sequences has led to the identification of an ESS and an adjacent positive element within that part of the EDA exon. The construct used in this study places the 3Јss of the alternatively spliced EDA exon in the context of a terminal exon. It has been demonstrated that even in this simplified context, recognition of the EDA 3Јss remains responsive to regulatory exon sequences both in vitro (32) and in vivo (2) . Therefore, we believe that conclusions drawn from this chimeric gene should be applicable to authentic EDA exon splicing regulation. Deletion studies mapped the 3Ј-boundary of the fibronectin ESS to nucleotide ϩ101 of the EDA exon. Actinomycin D time course experiments failed to detect a significant effect of exonic deletions on RNA stability; therefore, it can be concluded that the fibronectin ESS and the adjacent enhancer act at the level of splicing. Secondary structure prediction of the human EDA sequence and the alignment of the first 118 nucleotides of the EDA exon from various species combined with the mutagenesis data presented here implicate conserved secondary structures as critical determinants of ESS activity.
Because the ⌬1 truncation (which defines the 3Ј-boundary of the ESS) eliminates the third stem-loop, stem-loop 3 cannot be essential for ESS activity. In fact, we demonstrate that the region comprising stem-loop 3 harbors an ESE activity. This is discussed in more detail below. The mod3 mutation, which affects base pairs in stem-loop 1, resulted in a moderately increased (8-fold) level of splicing. Therefore, it can be concluded that the region comprising stem-loop 1 is required for maximal ESS activity. However, the relatively high splicing levels observed with the ⌬4 truncation indicate that sequences comprising stem-loop 1 have little ESS activity on their own in COS-7 cells. The SL1 mutations provide strong evidence that formation of the stem-loop 1 secondary structure rather than the primary sequence per se is essential for complete abrogation of splicing in the context of the ⌬1 truncation. Therefore, stem-loop 1 is required but not sufficient for maximal ESS activity in COS-7 cells.
Results with truncation mutants ⌬2, ⌬3, and ⌬4 revealed that splicing efficiency increased as increasing amounts of stem-loop 2 were removed. Both the mod1 and mod2 mutations, which affect base pairs in stem 2, resulted in a moderately increased (4 -6-fold) splicing efficiency. These results support the conclusion that the region comprising stem-loop 2 is an important determinant of ESS activity; however, they do not provide direct evidence that the predicted stem-loop 2 secondary structure is functionally important. The SL2 mutations, which target the lower stem of stem-loop 2, were designed to address this question. Analysis of these mutations revealed that formation of the lower stem of stem-loop 2 is not essential for ESS activity. Consistent with this observation, the ability to form the lower stem of stem-loop 2 is not well conserved in fibronectin sequences of chicken, newt, and frog. In these species, several disruptive substitutions are present on one strand of the predicted helix (Fig. 7B) . In contrast to the results obtained with the SL2B mutation, two other mutations that map to the base of stem-loop 2, mod1 and ⌬2, decreased ESS activity significantly. Because the mod1 mutation is in the context of FN-, some of the observed increase in splicing efficiency may be partly attributable to the downstream ESE, making the direct comparison of mod1 to ⌬2 and SL2B difficult. The fact that the mod1 mutation increases splicing and that FIG. 5 . Increased accumulation of spliced RNA is not caused by changes in RNA stability. COS-7 cells transfected with pSV␤FN-, pSV␤FN⌬4, or pSV␤FNmod3 were treated with 5 g/ml actinomycin D (Act D). Total RNA isolated at 0, 3, 6, and 9 h after the addition of the drug was analyzed by S1 nuclease protection. Unspliced and spliced RNA was quantitated and expressed as the percentage of the respective RNA (spliced or unspliced) at 0 h detected at the indicated time. Spliced RNA is indicated by filled circles and unspliced RNA by empty circles. Dotted, solid, and dashed lines represent pSV␤FN-, pSV␤FN⌬4, and pSV␤FNmod3, respectively. the ⌬2 and SL2B constructs, both of which do not contain the downstream ESE, have markedly different splicing efficiencies suggests that the affected nucleotide sequence at the base of putative stem-loop 2 plays an important role in ESS function. Computer prediction analysis of possible secondary structures carried out on the ⌬2 and SL2B mutations (data not shown) reveals that both destroy the ability to form putative stem-loop 2. However, in the case of the SL2B mutation, an alternate stable stem-loop containing extensive base pairing can form in its place. In contrast, no equally stable structure is predicted to form with the ⌬2 deletion. Therefore, it is possible that in addition to the primary sequence, certain base pairing interactions within the region of stem-loop 2 may also be important for ESS function. However, we do not yet understand the structural requirements of this region for ESS function, and in the absence of significant evolutionary covariation or conclusive experimental evidence we should emphasize the putative nature of stem-loop 2. Nonetheless, the data presented here clearly demonstrate that the region comprising putative stemloop 2 displays very strong ESS activity in COS-7 cells.
The total abrogation of splicing brought about by the ⌬1 deletion suggests the presence of an ESE that limits the effect FIG. 6 . Evidence for a novel, nonpurine-rich ESE within the EDA exon. Panel A, strategy to test if sequences adjacent to the ESS can stimulate splicing in a heterologous context. The plasmid pSVCBSB is identical to pSV␤FN-except that it contains the HIV sequences flanking the tat/rev 3Јss (47 nucleotides of intron and 5 nucleotides of exon sequences; depicted in black) instead of the fibronectin sequences flanking the EDA 3Јss. Sequences between ϩ93 and ϩ118 of the EDA exon (depicted in gray) were inserted in either the sense or antisense orientation into pSVCBSB to generate pSVCBSBFs and pSVCBSBFas, respectively. Panel B, S1 nuclease protection analysis was carried out using 10 g of total RNA from transfected COS-7 cells. Each sample was hybridized with the homologous probe as depicted in Fig. 1B . The probe used for analysis of pSVCBSB RNA extended into the ␤-globin exon sequences; hence, unspliced RNA appears as a band migrating slightly slower than that of its derivatives. Positions of the protected probe fragments are indicated on the left for pSVCBSB and the right for pSVCBSBFs and pSVCBSBFas: U, unspliced RNA; S, spliced RNA. Ratios of spliced to unspliced RNA are shown at the bottom of each lane. Panel C, summary of constructs used to study the nonpurine-rich enhancer. Sequences are shown in the 5Ј 3 3Ј orientation. The last three nucleotides of intron sequences are in lowercase Italics. The position of the 3Јss is depicted by the arrow. Exon sequences are in uppercase letters. The BamHI restriction endonuclease site and the BglII/BamHI junction are in lowercase letters to emphasize the boundaries of HIV-1, fibronectin, and polylinker sequences. Shown from top to bottom are the parent pSVCBSB, which contains no insert (indicated by the gap), pSVCBSBFas, pSVCBSBFs, pSVCBSBFsϩ1C, pSVCBSBFs⌬5Јss, and pSVCBSBFs⌬AC. The pseudo-5Јss discussed in the text is underlined. The G 3 C mutation introduced at position ϩ1 of the pseudo-5Јss is in thin type. Panel D, S1 nuclease protection analysis was carried out using 10 g of total RNA from transfected COS-7 cells. Each sample was hybridized with the homologous probe as depicted in Fig.  1B . The probe used for analysis of pS-VCBSB RNA extended into the ␤-globin exon sequences; hence, unspliced RNA appears as a band migrating slightly slower than that of its derivatives. Positions of the protected probe fragments are indicated on the left for pSVCBSB and the right for its derivatives: U, unspliced RNA; S, spliced RNA. Ratios of spliced to unspliced RNA are shown at the bottom of each lane.
of the adjacent ESS. This organization of splicing control elements is reminiscent of the adjacent enhancer and silencer elements identified in the terminal HIV-1 tat/rev exon (2). Unlike most exonic splicing enhancers identified to date (39 -41) , the sequence associated with this particular splicing enhancer is not purine-rich and thus not a classical ESE. Nonetheless, this novel enhancer is functionally equivalent to classical ESEs because it too can stimulate splicing of an ESEdependent intron in an orientation-dependent fashion. Sequence analysis of this region raised the possibility that the enhancing activity could be attributed to the presence of a pseudo-5Јss. In other systems, 5Јss-like elements have been shown to contribute to modulation of splicing both negatively as in the case of the Drosophila P element (11) and positively as in the case of the human calcitonin/calcitonin gene-related peptide gene (17) . However, analogous regions of homology to the 5Јss consensus can also be identified within the antisense orientation, which was found to have no ESE activity. Disruption of the pseudo-5Јss by either a point mutation or deletion did not abolish ESE activity; rather, the mutations resulted in a marked enhancement of splicing. These results indicate that the 5Јss-like element is not required for enhancer activity of this sequence. In contrast, the result obtained with the ⌬AC derivative suggests that the region comprising the 5Јss-like element can stimulate splicing in the absence of downstream fibronectin sequences. Therefore, it is possible that two distinct non-purine-rich stimulatory elements are present between nucleotides ϩ93 and ϩ118 of the fibronectin EDA exon. A similar non-purine-rich exon element that stimulates splicing of the upstream intron by stabilizing the interaction between U2AF Michael Zucker's on-line mfold RNA folding software (http://www.ibc.wustl.edu/ ϳzuker/rna/form1.cgi) was used. The stem-loops are labeled 1, 2, and 3. The structure has a predicted energy of Ϫ38 kcal/mol. The positions of the deletions (arrowheads) and modified regions (highlighted in gray) are as described in Fig. 2 . The predicted base pairs that are targeted by the SL1 or SL2 mutations are boxed. Evolutionary and experimental evidence presented in panels B and C provides strong evidence for the formation of stemloop 1. To date, evidence for the formation of stem-loop 2 is insufficient. Thus, its formation remains speculative. Panel B, nucleotide sequence alignment of the EDA exon from various species. The stemloops shown in panel A are outlined by arrows above the sequence. Dots denote conserved positions. Uppercase letters denote substitutions that do not destroy the predicted secondary structure. Lowercase letters denote substitutions that disrupt base pairing in the predicted secondary structure. H denotes the sequence for human fibronectin; D for dog (Canis familiaris), accession no. U16207; R for rat (Rattus norvegicus), accession no. M11750; M for mouse (Mus musculus), accession no. X93167; C for chicken (Gallus gallus), accession no. U21237; N for newt (Pleurodeles waltl), accession no. X66813; and F for frog (Xenopus laevis), accession no. M77820. Relevant portions of the SL1B, SL1TB, SL2B, and SL2TB mutations are also shown. As described under "Experimental Procedures," the last four are in the context of the ⌬1 truncation and hence include up to nucleotide ϩ101 of the EDA exon. For further explanation, see "Results." Panel C, introduction of compensatory mutations in putative stem-loops 1 and 2 of the ESS. The SL1B, SL1TB, SL2B, and SL2TB mutations are described in panel B. S1 nuclease protection analysis was carried out using 10 g of total RNA from transfected COS-7 cells. Each sample was hybridized with the homologous probe as depicted in Fig. 1B . Positions of the protected probe fragments are indicated: U, unspliced RNA; S, spliced RNA. Ratios of spliced to unspliced RNA are shown at the bottom of each lane. and the polypyrimidine tract has been described in troponin T exon 16 (48) . Interestingly, the two mutations designed to alter the 5Јss-like element increase the overall A/C content of the test sequence. Therefore, this newly identified positive element may be an example of a class of A/C-rich enhancer elements which has been described to be functionally equivalent to purine-rich ESEs (49) . It is noteworthy to point out that most of the substitutions that are observed between ϩ86 and ϩ118 in fibronectin sequences of chicken, newt, and frog also increase the overall A/C content. We speculate that in these organisms perhaps the strength of the enhancer is increased at the expense of the strength of the silencer.
At least two general mechanisms could explain the modulatory effect of the elements identified in the EDA exon: (i) they contribute to a secondary structure that simply impedes proper recognition of the 3Јss; or (ii) specific cellular trans-acting factors interact with these elements to modulate the efficiency with which the 3Јss is recognized. The sequences at the intron/ exon junction surrounding the EDA 3Јss have previously been proposed to form an alternate secondary structure involving base pairing between intronic and exonic sequences to form a single stem-loop interrupted by several bulges (50) . Within this structure, the AG dinucleotide of the EDA 3Јss is buried within the predicted secondary structure. Data presented in this study are inconsistent with the structure reported previously as being of functional importance. The SL1 mutations provide compelling evidence that stem-loop 1 as predicted in Fig. 7A is indeed a determinant of the ESS. Consequently, if RNA structure alone is involved in modulation of 3Јss recognition, it must involve more complex tertiary interactions that cannot be predicted by the folding programs used.
We describe here the initial identification of an exonic element within the EDA exon of human fibronectin which has a dramatic down-regulatory effect on splicing. This novel ESS lies adjacent to a non-purine-rich region that is demonstrated to stimulate splicing in several contexts. Why should an alternatively spliced exon have so many cis-acting elements that modulate its inclusion into mRNA? In the case of the fibronectin EDA exon, it is possible that several distinct elements regulate its inclusion in both a tissue-specific and developmental stage-specific fashion as well as in response to certain external stimuli. Therefore, we can envision several parallel splicing regulatory circuits that interact with various regulatory trans-acting factors to bring about the spectrum of EDA exon inclusion observed in different tissues at different stages under different conditions. Now that several cis-acting modulatory elements have been identified, it will be of interest to identify the trans-acting factors and determine their individual as well as their collective mechanisms of action.
